MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0008364
Denizen Pharmaceuticals India Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.51 Cr
▲ 125% YoY
Net profit · FY 2025
₹4.45 Lakh
Net margin 1%
EBITDA · FY 2025
₹7.26 Lakh
EBITDA margin 1.6%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹24.75 Lakh
Issued & subscribed
Open charges
₹70 Lakh
Secured borrowings
Company age
33 yrs
Est. 1993
Directors on board
3
As per MCA filings
About Denizen Pharmaceuticals India Private Limited
Data last updated:
Denizen Pharmaceuticals India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 December 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1993PTC056429. Its GSTIN is 07AAACD3875H1ZM (Delhi).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹24.75 Lakh. It is led by directors including Nikunj Gupta and Anuj Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Wz – 8 First Floor Manohar Park Opposite Metro Pillar No. 41 Rohtak Roa, D, New Delhi, Delhi, India – 110026.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.51 Cr, a growth of 125% compared to the previous year. For the same year it recorded a net profit of ₹4.45 Lakh (net margin 1%) and EBITDA of ₹7.26 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 25% over five years.
As per MCA filings, the company has open charges of ₹70 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
Denizen Pharmaceuticals India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0008364). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website denizenpharmaceuticals.com.
Company details
CIN U74899DL1993PTC056429
Registration Number 056429
Incorporation Date 13 December 1993
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0008364
Recognitions & Rankings of Denizen Pharmaceuticals India
Contact details
Denizen Pharmaceuticals India Private Limited's registered office is in New Delhi, Delhi. Its website is denizenpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressWz – 8 First Floor Manohar Park Opposite Metro Pillar No. 41 Rohtak Roa, D, New Delhi, Delhi, India – 110026
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Denizen Pharmaceuticals India Private Limited, buy the company report.
Comprehensive company report
Denizen Pharmaceuticals India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Denizen Pharmaceuticals India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Denizen Pharmaceuticals India Private Limited, buy the company report.
Financials of Denizen Pharmaceuticals India Private Limited
FY 2024 filings availableDenizen Pharmaceuticals India Private Limited reported revenue of ₹4.51 Cr (up 125% YoY) for FY 2025.
Revenue · FY 2025
₹4.51 Cr ▲ 125%
Net profit · FY 2025
₹4.45 Lakh margin 1%
EBITDA · FY 2025
₹7.26 Lakh margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 125%
3 years · compounded
▲ 33%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▼ 14%
3 years · compounded
▲ 17%
5 years · compounded
▲ 40%
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 125% growth in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Denizen Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Denizen Pharmaceuticals India Private Limited
Denizen Pharmaceuticals India has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikunj Gupta Also directs: Promvin Biotech Private Limited | Director | 04 Jul 2012 | 14 Years 4 Months | Current |
| Anuj Gupta Also directs: Mustcure Healthcare LLP, Cosmile Care Private Limited | Director | 04 Jul 2012 | 14 Years 4 Months | Current |
| Praveen Kumar Gupta Also directs: Nikvin Healthcare (India) Private Limited | Director | 13 Dec 1993 | 32 Years 10 Months | Current |
Peer comparison
Denizen Pharmaceuticals India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SGS Formulation Private Limited | ₹4.52 Cr (FY 2025) | -21.0% | Thiruvallur, Tamil Nadu, India | |||
| Denizen Pharmaceuticals India Private Limitedthis company | ₹4.51 Cr (FY 2025) | ₹4.45 Lakh | 1% | 125.0% | New Delhi, Delhi, India | |
| S N D Life Science Private Limited | ₹4.5 Cr (FY 2024) | 98.0% | Navi Mumbai, Maharashtra, India | |||
| Astrazen Pharmaceuticals Private Limited | ₹4.5 Cr (FY 2025) | 4.0% | Panchkula, Haryana, India | |||
| S P M Drugs Private Limited | ₹4.49 Cr (FY 2025) | -30.0% | Erode, Tamil Nadu, India |
To see the full peer comparison of Denizen Pharmaceuticals India Private Limited, buy the company report.
Auditor
Denizen Pharmaceuticals India Private Limited is audited by Harish Devesh & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Harish Devesh & Associates | FY 2023 | 013094N |
Shareholding
The shareholding of Denizen Pharmaceuticals India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Denizen Pharmaceuticals India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹70 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jun 2025 | 101110536 | Others | ₹70 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Denizen Pharmaceuticals India Private Limited has 2 court cases on record: 2 filed by Denizen Pharmaceuticals India. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Cheque dishonour complaint | Filed by the company against Ms Sitra Biotech Pvt Ltd | Pending |
| District court, West, Delhi | Civil suit | Filed by the company against individuals | Disposed |
To see the full case history of Denizen Pharmaceuticals India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Denizen Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Denizen Pharmaceuticals India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACD3875H1ZM | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Denizen Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Denizen Pharmaceuticals India Private Limited has 5 board changes on record since 1993: 3 appointments and 2 cessations. The latest: Anuj Gupta was appointed as Director on 04 Jul 2012.
Charges
A charge with Others amounted to Rs. 70.00 Lakh with Charge ID 101110536 was registered on 06 Jun 2025.
AGM
Denizen Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Denizen Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Anuj Gupta was appointed as Director.
Ceased
Dhiraj Kumar Gupta ceased to be Director.
Ceased
Navin Kumar Gupta ceased to be Director.
Appointed
Nikunj Gupta was appointed as Director.
Appointed
Praveen Kumar Gupta was appointed as Director.
Incorporation
13 Dec 1993
Denizen Pharmaceuticals India Private Limited was registered on 13 Dec 1993 with Roc Delhi & aged 32 years 10 months as per MCA records.
Frequently asked questions
Denizen Pharmaceuticals India is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 December 1993 (33+ years old) and is registered under CIN U74899DL1993PTC056429.
Denizen Pharmaceuticals India has 3 current directors:
- Nikunj Gupta - Director
- Anuj Gupta - Director
- Praveen Kumar Gupta - Director
The latest financial statements of Denizen Pharmaceuticals India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Denizen Pharmaceuticals India is 07AAACD3875H1ZM, registered in Delhi.
The CIN (Corporate Identification Number) of Denizen Pharmaceuticals India is U74899DL1993PTC056429. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Denizen Pharmaceuticals India has 2 court cases on record: 2 filed by the company. 1 is pending.
Denizen Pharmaceuticals India was incorporated on 13 December 1993, making it 33+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Denizen Pharmaceuticals India by revenue are SGS Formulation Private Limited, S N D Life Science Private Limited, Astrazen Pharmaceuticals Private Limited, S P M Drugs Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anuj Gupta was appointed as Director on 04 Jul 2012. Dhiraj Kumar Gupta ceased to be Director on 04 Jul 2012. Navin Kumar Gupta ceased to be Director on 04 Jul 2012. Denizen Pharmaceuticals India has 5 board changes on record in total.
Yes, Denizen Pharmaceuticals India is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0008364).
Denizen Pharmaceuticals India can be reached through the website denizenpharmaceuticals.com. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages